Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-11-071902
Filing Date
2011-12-28
Accepted
2011-12-28 16:25:21
Documents
13
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A v239327_10ka.htm 10-K/A 1684164
2 EXHIBIT 23.1 v239327_ex23-1.htm EX-23.1 4017
3 EXHIBIT 23.2 v239327_ex23-2.htm EX-23.2 7438
4 EXHIBIT 31.1 v239327_ex31-1.htm EX-31.1 11816
5 EXHIBIT 31.2 v239327_ex31-2.htm EX-31.2 12971
6 EXHIBIT 32.1 v239327_ex32-1.htm EX-32.1 6374
7 EXHIBIT 32.2 v239327_ex32-2.htm EX-32.2 6901
9 GRAPHIC footer.jpg GRAPHIC 3354
10 GRAPHIC header.jpg GRAPHIC 8955
11 GRAPHIC logo.jpg GRAPHIC 10979
12 GRAPHIC logo3.jpg GRAPHIC 13977
13 GRAPHIC report.jpg GRAPHIC 6795
14 filename14.htm CORRESP 26537
  Complete submission text file 0001144204-11-071902.txt   1822835
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10019
Business Address 110 EAST 59TH STREET NEW YORK NY 10019 250-519-0553
BRAINSTORM CELL THERAPEUTICS INC (Filer) CIK: 0001137883 (see all company filings)

EIN.: 912061050 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-54365 | Film No.: 111284147
SIC: 2836 Biological Products, (No Diagnostic Substances)